Contineum Therapeutics Inc. Class A Common Stock (CTNM) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Contineum Therapeutics In...

    NASDAQ: CTNM · Real-Time Price · USD
    11.35
    0.60 (5.58%)
    At close: Oct 03, 2025, 3:59 PM
    11.13
    -1.94%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Contineum Therapeutics Class A Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -42.26M 22.72M -24.25M -29M
    Depreciation & Amortization
    		 258K 195K 329K 325K
    Stock-Based Compensation
    		 6.8M 2.22M 1.93M 1.75M
    Other Working Capital
    		 4.19M -1.02M -1.04M 218K
    Other Non-Cash Items
    		 -2.98M -4.76M 5.96M 164K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 5.33M -1.02M -1.27M 108K
    Operating Cash Flow
    		 -32.84M 19.35M -20.12M -26.27M
    Capital Expenditures
    		 -514K -414K -118K -168K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -226.41M -141.87M -64.7M -66.78M
    Sales Maturities Of Investments
    		 157.16M 76.71M 87.12M 1.98M
    Other Investing Acitivies
    		 20K n/a 22.42M -64.8M
    Investing Cash Flow
    		 -69.74M -65.57M 22.3M -64.97M
    Debt Repayment
    		 n/a -3.75M -1.25M n/a
    Common Stock Repurchased
    		 n/a -28K -4K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 790K -184K 15K 113K
    Financial Cash Flow
    		 109M 56.18M -1.24M 79.84M
    Net Cash Flow
    		 6.42M 9.96M 939K -11.39M
    Free Cash Flow
    		 -33.36M 18.93M -20.24M -26.43M

    Add to Watchlist